| Stage | OMC | % of rev | CRTO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.4B | 100.00% | $428M | 100.00% | OMC ×15.01 |
| Gross profit | $1.4B | 21.16% | $222M | 51.92% | CRTO +30.8pp |
| Operating income | $992M | 15.44% | $15M | 3.51% | OMC +11.9pp |
| Pre-tax income | $888M | 13.82% | $15M | 3.58% | OMC +10.2pp |
| Net income | $675M | 10.50% | $12M | 2.75% | OMC +7.8pp |
| Stage | OMC | CRTO | Gap · A − B |
|---|---|---|---|
| Revenue | $6.4B100.00% | $428M100.00% | OMC ×15.01 |
| Gross profit | 21.16%$1.4B | 51.92%$222M | CRTO +30.8pp |
| Operating income | 15.44%$992M | 3.51%$15M | OMC +11.9pp |
| Pre-tax income | 13.82%$888M | 3.58%$15M | OMC +10.2pp |
| Net income |
| 10.50%$675M |
| 2.75%$12M |
| OMC +7.8pp |